CTOs on the Move

Profusa

www.profusa.com

 
Profusa, Inc. is leading the development of a new generation of biologically integrated sensors that empowers an individual with the ability to continuously monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Overcoming the bodys response to foreign material, the companys technology enables the development of minute bioengineered sensors that become one with the body to detect and transmit clinical-grade data for personal and medical use.
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.profusa.com
  • 345 Allerton Ave South
    San Francisco, CA USA 94080
  • Phone: 415.655.9861

Executives

Name Title Contact Details

Funding

Profusa raised $13.2M on 12/16/2015
Profusa raised $45M on 08/14/2018

Similar Companies

Obbligato Objectives

Obbligato Objectives is a Scarborough, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rynel

Rynel is a Wiscasset, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Taut

Taut, Inc. is a Geneva, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mizuho OSI

Mizuho OSI is a Union City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Glaukos

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.